The estimated Net Worth of Robert C Reindl is at least $7.21 Milione dollars as of 27 July 2012. Robert Reindl owns over 57,464 units of Edwards Lifesciences Corp stock worth over $76,713 and over the last 21 years Robert sold EW stock worth over $7,137,351.
Robert has made over 9 trades of the Edwards Lifesciences Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently Robert sold 57,464 units of EW stock worth $6,019,929 on 27 July 2012.
The largest trade Robert's ever made was selling 57,464 units of Edwards Lifesciences Corp stock on 27 July 2012 worth over $6,019,929. On average, Robert trades about 6,428 units every 106 days since 2003. As of 27 July 2012 Robert still owns at least 1,124 units of Edwards Lifesciences Corp stock.
You can see the complete history of Robert Reindl stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo e Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: